ArticleInternational journal of clinical and experimental medicine2015

Integrin beta-8 (ITGB8) silencing reverses gefitinib resistance of human hepatic cancer HepG2/G cell line.

Wei-Wei Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.